The FDA approval process did not need to review the VAERS data, because Comirnaty is not in the VAERS database as it's not US manufactured. Had they tried approving BNT162B2, they would have had to address the thousands of deaths and other serious adverse effects reported. Since the US doesn't have any reports of deaths/adverse reactions to Comirnaty, go ahead and approve away. After all it has the presence of optimized codons for improved antigen expression.
This suggests to me that they changed the name (or gave it the name it was always intended to have) from BNT162B2 (Mr. Unpronounceable) to Comirnaty (slightly better).
But changing the name on a product does not require additional trials, or anything except a formal submission of name change (which is likely part of the approval process). It is the same product by serial number. It is the serial number that has been approved. It may very well be weasely, but how exactly is not obvious, nor would such an act be among their more heinous crimes.
Please let me know if you can find evidence of a single dose of Comirnaty in the United States for use.
If it is in fact just a name change, approval for the serial number would be approval for the vaccine by any name.
This suggests to me that they changed the name (or gave it the name it was always intended to have) from BNT162B2 (Mr. Unpronounceable) to Comirnaty (slightly better).
But changing the name on a product does not require additional trials, or anything except a formal submission of name change (which is likely part of the approval process). It is the same product by serial number. It is the serial number that has been approved. It may very well be weasely, but how exactly is not obvious, nor would such an act be among their more heinous crimes.
If it is in fact just a name change, approval for the serial number would be approval for the vaccine by any name.